Showing results (11-20 of 17) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
European Journal of Immunology|November 10, 1998
IL-15-IgG2b fusion protein accelerates and enhances a Th2 but not a Th1 immune response in vivo, while IL-2-IgG2b fusion protein inhibits bothR Rückert, U Herz, R Paus, et al.VASA. Zeitschrift Fur Gefasskrankheiten|November 13, 2008
Design and rationale of a randomized, double-blind, placebo-controlled phase III study for autologous bone marrow cell transplantation in critical limb ischemia: the BONe Marrow Outcomes Trial in Critical Limb Ischemia (BONMOT-CLI)B Amann, C Lüdemann, R Rückert, et al.Nature Medicine|October 23, 1997
Interleukin-15 protects from lethal apoptosis in vivoS Bulfone-Paus, D Ungureanu, T Pohl, et al.The British Journal of Dermatology|May 16, 2000
The human hair follicle immune system: cellular composition and immune privilegeT Christoph, S Müller-Röver, H Audring, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 5, 2000
Inhibition of keratinocyte apoptosis by IL-15: a new parameter in the pathogenesis of psoriasis?R Rückert, K Asadullah, M Seifert, et al.Transplantation|May 8, 2000
An interleukin-2-IgG-Fas ligand fusion protein suppresses delayed-type hypersensitivity in mice by triggering apoptosis in activated T cells as a novel strategy for immunosuppressionS Bulfone-Paus, R Rückert, H Krause, et al.Cancer Research|July 14, 1998
Vaccination with tumor cells engineered to secrete interleukin 2-immunoglobulin G fusion protein induces tumor rejectionS Bulfone-Paus, H von Bernuth, R Rückert, et al.Pageof 2